The Novo Nordisk Investigator Sponsored Studies (ISS) Program will accept submissions within our current scientific focus areas as noted below. This is a competitive process. Incomplete submissions or protocols that are not within the scope of these focus areas/have low relevance to the therapeutic area may be rejected without further review. Submissions will be reviewed by the relevant Novo Nordisk teams. Decisions will be made based on scientific merit and strategic fit. Please review the submission requirements. The program requests that investigators specify how they will support enrollment of diverse populations in the study.